Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tyra Biosciences, Inc. - Common Stock (NQ:TYRA)

35.27 -0.35 (-0.98%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,416,033
Open 35.94
Bid (Size) 35.35 (400)
Ask (Size) 35.94 (400)
Prev. Close 35.62
Today's Range 35.13 - 36.58
52wk Range 7.800 - 40.65
Shares Outstanding 43,010,692
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This Biotech Stock Has Surged 250% in a Year as One Investor Discloses $10 Million New Position ↗
This biotech firm develops targeted oncology therapies and leverages proprietary technology to address tumor resistance mechanisms. 
Via The Motley Fool
News headline image
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗
Relay Therapeutics develops precision oncology medicines using proprietary computational modeling and strategic industry partnerships. 
Via The Motley Fool

Performance

YTD
+31.7%
+31.7%
1 Month
-4.7%
-4.7%
3 Month
+22.6%
+22.6%
6 Month
+145.6%
+145.6%
1 Year
+318.4%
+318.4%

More News

Read More
News headline image
Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Jumps 288% Amid Massive Raise as One Early Backer Reports $14 Million Exit ↗
Via The Motley Fool
News headline image
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit ↗
Via The Motley Fool
News headline image
From Sizable Stake to Zero: The Likely Reason Why Agios Shares Lost a $94 Million Backer ↗
Via The Motley Fool
News headline image
Viridian Therapeutics Stock Up 75%, but One Fund Just Sold Off Its $69 Million Stake ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Spyre Therapeutics Stock Surges This Past Year as $10.5 Million Buy Lifts Stake to $78 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Fund Dumps $84 Million of Nuvalent With Stock Up 29% ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tyra Biosciences Narrows Loss in Q2 ↗
Via The Motley Fool
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
Via Chartmill
News headline image
Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why WaFd Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Neumora Therapeutics, XPeng And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Why Is Cancer-Focused Tyra Biosciences Stock Falling On Friday? ↗
Via Benzinga
News headline image
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug ↗
Via Benzinga

Frequently Asked Questions

Is Tyra Biosciences, Inc. - Common Stock publicly traded?
Yes, Tyra Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Tyra Biosciences, Inc. - Common Stock trade on?
Tyra Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tyra Biosciences, Inc. - Common Stock?
The ticker symbol for Tyra Biosciences, Inc. - Common Stock is TYRA on the Nasdaq Stock Market
What is the current price of Tyra Biosciences, Inc. - Common Stock?
The current price of Tyra Biosciences, Inc. - Common Stock is 35.27
When was Tyra Biosciences, Inc. - Common Stock last traded?
The last trade of Tyra Biosciences, Inc. - Common Stock was at 04/14/26 04:00 PM ET
What is the market capitalization of Tyra Biosciences, Inc. - Common Stock?
The market capitalization of Tyra Biosciences, Inc. - Common Stock is 1.52B
How many shares of Tyra Biosciences, Inc. - Common Stock are outstanding?
Tyra Biosciences, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.